CEBPA and Hepatic fibrosis: Treatment with carbon tetrachloride (CCl4, commonly used drugs to induce cirrhosis in animals) has been shown to cause hepatic fibrosis and decrease C/EBPα level in the livers of mice [28, 37, 115].